Regulus Therapeutics (RGLS) Names Timothy Wright Chief Research and Development Officer
Go back to Regulus Therapeutics (RGLS) Names Timothy Wright Chief Research and Development OfficerREGULUS THERAP (NASDAQ: RGLS) | Delayed: 2.20 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $2.20 | 52 Week High | $10.60 | |||
Open | $2.20 | 52 Week Low | $2.13 | |||
Day High | $2.20 | P/E | 0.06 | |||
Day Low | $2.20 | EPS | $38.45 | |||
Volume | 1,700 |